Skip to main content

Alignment Healthcare (ALHC) Q3 Earnings Report Preview: What To Look For

ALHC Cover Image

Health insurance company Alignment Healthcare (NASDAQ: ALHC) will be announcing earnings results this Thursday after market hours. Here’s what to expect.

Alignment Healthcare beat analysts’ revenue expectations by 5.7% last quarter, reporting revenues of $1.02 billion, up 49% year on year. It was an exceptional quarter for the company, with a beat of analysts’ EPS estimates and a solid beat of analysts’ revenue estimates. It added 6,200 customers to reach a total of 223,700.

Is Alignment Healthcare a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.

This quarter, analysts are expecting Alignment Healthcare’s revenue to grow 41.7% year on year to $981.5 million, slowing from the 51.6% increase it recorded in the same quarter last year. Adjusted loss is expected to come in at -$0.01 per share.

Alignment Healthcare Total Revenue

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Alignment Healthcare has a history of exceeding Wall Street’s expectations, beating revenue estimates every single time over the past two years by 4.8% on average.

Looking at Alignment Healthcare’s peers in the health insurance providers segment, some have already reported their Q3 results, giving us a hint as to what we can expect. Elevance Health delivered year-on-year revenue growth of 11%, meeting analysts’ expectations, and Molina Healthcare reported revenues up 11%, topping estimates by 4.7%. Elevance Health traded down 2.5% following the results while Molina Healthcare was also down 17.3%.

Read our full analysis of Elevance Health’s results here and Molina Healthcare’s results here.

There has been positive sentiment among investors in the health insurance providers segment, with share prices up 6.1% on average over the last month. Alignment Healthcare is up 1.2% during the same time and is heading into earnings with an average analyst price target of $19.25 (compared to the current share price of $17.66).

P.S. While everyone's chasing Nvidia, we found a hidden AI semiconductor winner trading at a fraction of the price. See our #1 pick before Wall Street catches on.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  230.30
+1.05 (0.46%)
AAPL  269.70
+0.70 (0.26%)
AMD  264.33
+6.32 (2.45%)
BAC  52.58
-0.29 (-0.55%)
GOOG  275.17
+6.74 (2.51%)
META  751.67
+0.23 (0.03%)
MSFT  541.55
-0.52 (-0.10%)
NVDA  207.04
+6.01 (2.99%)
ORCL  275.30
-5.53 (-1.97%)
TSLA  461.51
+0.96 (0.21%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.